Dr. Radhakrishnan Ramchandren, MD ...

Dr. Radhakrishnan Ramchandren, M.D.

Claim this profile

University of Tennessee

Studies Central Nervous System Hodgkin Lymphoma
Studies Hodgkin's Lymphoma
7 reported clinical trials
13 drugs studied

Area of expertise

1

Central Nervous System Hodgkin Lymphoma

Radhakrishnan Ramchandren, M.D. has run 3 trials for Central Nervous System Hodgkin Lymphoma. Some of their research focus areas include:

Stage I
Stage IV
Stage III
2

Hodgkin's Lymphoma

Radhakrishnan Ramchandren, M.D. has run 3 trials for Hodgkin's Lymphoma. Some of their research focus areas include:

Stage I
Stage IV
Stage III

Affiliated Hospitals

Image of trial facility.

University Of Tennessee

Image of trial facility.

University Of Tennessee Medical Center Cancer Institute

Clinical Trials Radhakrishnan Ramchandren, M.D. is currently running

More about Radhakrishnan Ramchandren, M.D.

Clinical Trial Related

4 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Radhakrishnan Ramchandren, M.D. has experience with

  • Brentuximab Vedotin
  • Doxorubicin
  • Lenalidomide
  • Rituximab
  • Nivolumab
  • Dacarbazine

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Radhakrishnan Ramchandren, M.D. specialize in?

Is Radhakrishnan Ramchandren, M.D. currently recruiting for clinical trials?

Are there any treatments that Radhakrishnan Ramchandren, M.D. has studied deeply?

What is the best way to schedule an appointment with Radhakrishnan Ramchandren, M.D.?

What is the office address of Radhakrishnan Ramchandren, M.D.?

Is there any support for travel costs?